2025 Regulatory Workshop - Panel: Evolving Allergen Risks, Regulatory Perspectives, and Global Approaches
This panel session focused on FDA’s recent guidance and industry engagement on allergens, including the agency’s current thinking on labeling, enforcement, and thresholds, as well as provided insight on how global regulatory bodies are approaching allergen management. Attendees learned more about how the growing regulatory focus on allergens may have an impact on operations and also walked through how allergen risk assessments may be conducted for spices.
You must be registered for the 2025 Regulatory Workshop and logged in as a member to access these materials.
Related Resources
2025 ASTA Regulatory Workshop, Keynote Address
Mark Hartman, Director of Office of Food Chemical Safety, Dietary Supplements and Innovation at the Food and Drug Administration talks about the agency’s priorities and how the spice industry and FDA can work together to promote a U.S. food system.
2025 Regulatory Workshop - ASTA Advocacy Update
ASTA’s advocacy team and partners provided an insider’s look at the evolving trade and tariff landscape impacting the spice industry. Panelists shared updates on key negotiations and policy developments, highlighted ASTA’s public affairs and coalition-building efforts, and provided insights from outreach with U.S. and international policymakers. This session also featured a moderated Q&A exploring the success of ASTA’s advocacy efforts.
